Project ID: 94506

Chinese government provides 50,000 COVID-19 vaccines to Bosnia and Herzegovina in April 2021

Commitment amount

$ 900000.0

Adjusted commitment amount

$ 900000.0

Constant 2021 USD

Summary

Funding agency [Type]

Unspecified Chinese Government Institution [Government Agency]

Recipient

Bosnia and Herzegovina

Sector

Health (Code: 120)

Flow type

Grant

Infrastructure

No

COVID

Yes

Category

Intent

Development (The next section lists the possible statuses.)

Commercial

Development

Representational

Mixed

Financial Flow Classification

ODA-like (The next section lists the possible statuses.)

Official Development Assistance

Other Official Flows

Vague (Official Finance)

Flows categorized based on OECD-DAC guidelines

Project lifecycle

Status

Completion (The next section lists the possible statuses.)

Pledge

Commitment

Implementation

Completion

Suspended

Cancelled

Milestones

Commitment

2021-04-29

Actual start

2021-04-29

Actual complete

2021-04-29

Description

On April 29, 2021, the Chinese government provided 50,000 doses of the Sinopharm Covid-19 vaccine to Bosnia and Herzegovina. According to the Chinese Embassy in Bosnia and Herzegovina, this donation represents cooperation between China and Bosnia and Herzegovina as well as China's commitment to helping the country overcome COVID-19. A handover ceremony was held for this donation in Sarajevo, the capital city of Bosnia and Herzegovina. Ji Ping, the Chinese Ambassador to Bosnia and Herzegovina, attended the ceremony and delivered a speech as did Minister of Civil Affairs of Bosnia and Herzegovina, Ankica Gudeljevic.

Additional details

AidData has estimated the transaction amount for this donation based on price catalogues from the World Health Organization (WHO). Please see the TUFF Methodology for additional details.

Number of official sources

4

Number of total sources

6

Download the dataset

Details

Cofinanced

No

Direct receiving agencies [Type]

Government of Bosnia and Herzegovina [Government Agency]

Implementing agencies [Type]

China National Pharmaceutical Group Corporation (Sinopharm) [State-owned Company]